Dark

AXSM
Axsome Therapeutics, Inc
stock NASDAQ

At Close

Oct 2, 2026 3:59:56 PM EDT

179.03USD-1.670%(-3.04)982,669

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 1, 2026 8:06:30 AM EDT

184.39USD+1.274%(+2.32)0

After-hours

Oct 2, 2026 4:35:30 PM EDT

179.40USD+0.207%(+0.37)200

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

9.39B

CEO

Herriot Tabuteau

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Nov 2, 2026 (30d)

PDLI PIRS XLV

AXSM Stats

Avg. Vol. 10 Day

782,921

Avg. Vol. 30 Day

652,906

Employees

Market Cap

9,389,785,435

Shares Out.

52,380,818

On/Off Exchange

53%/48%

6 Month Beta

0.76

1 Year Beta

0.62

2 Year Beta

0.68

3 Year Beta

0.72

52 Week Low

117.30

52 Week High

260.19

SMA50

210.66

SMA200

199.62

1 Week

-8.11%

1 Month

-14.61%

3 Month

-26.63%

6 Month

+6.38%

1 Year

+49.46%

2 Year

+92.26%

5 Year

+422.93%

Profile

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.

AXSM Stock Summary

Axsome Therapeutics, Inc (NASDAQ:AXSM) stock price today is $179.03, and today's volume is 982,669. AXSM is down -1.670% today. The 30 day average volume is 652,906. AXSM market cap is 9.39B with 52,380,818 shares outstanding.

.dark-mode .mtNqST{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .mtNqST{ color: #333333; background-color: white; border: 2px solid #333333; }AXSMAxsome Therapeutics, Incstock NASDAQ

AXSM Stock Summary

AXSM
Axsome Therapeutics, Inc
stock NASDAQ